Gratus Capital LLC Amgen Inc Transaction History

Gratus Capital LLC

$2.1 Billion
Q1 2024

A detailed history of Gratus Capital LLC transactions in Amgen Inc stock. As of the latest transaction made, Gratus Capital LLC holds 46,570 shares of AMGN stock, worth $15 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares

46,570

Previous 45,544 2.25%

Holding current value

$15 Million

Previous $13.1 Million 0.94%

% of portfolio

0.63%

Previous 0.77%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $275,860 - $332,998	1,026 Added 2.25%	46,570 $13.2 Million
Q4 2023 Feb 07, 2024	SELL	$255.7 - $288.46 $199,701 - $225,287	-781 Reduced 1.69%	45,544 $13.1 Million
Q3 2023 Oct 26, 2023	BUY	$218.65 - $271.46 $66,250 - $82,252	303 Added 0.66%	46,325 $12.5 Million
Q2 2023 Aug 02, 2023	BUY	$214.27 - $253.37 $235,482 - $278,453	1,099 Added 2.45%	46,022 $10.2 Million
Q1 2023 Apr 19, 2023	SELL	$225.79 - $275.2 $248,369 - $302,720	-1,100 Reduced 2.39%	44,923 $10.9 Million

Q4 2022 Jan 27, 2023	BUY	$229.03 - $291.01 $9.87 Million - $12.5 Million	43,101 Added 1475.05%	46,023 $0
Q3 2022 Nov 03, 2022	SELL	$224.46 - $253.15 $53,421 - $60,249	-238 Reduced 7.53%	2,922 $659,000
Q2 2022 Jul 29, 2022	BUY	$230.71 - $256.74 $155,267 - $172,786	673 Added 27.06%	3,160 $769,000
Q1 2022 Apr 29, 2022	SELL	$219.27 - $242.57 $19,515 - $21,588	-89 Reduced 3.45%	2,487 $602,000
Q4 2021 Jan 31, 2022	BUY	$198.88 - $227.6 $3,778 - $4,324	19 Added 0.74%	2,576 $580,000
Q3 2021 Nov 05, 2021	SELL	$212.27 - $248.7 $112,715 - $132,059	-531 Reduced 17.2%	2,557 $544,000
Q2 2021 Aug 10, 2021	SELL	$233.58 - $259.14 $470,897 - $522,426	-2,016 Reduced 39.5%	3,088 $753,000
Q4 2020 Feb 03, 2021	BUY	$216.38 - $257.67 $22,936 - $27,313	106 Added 2.12%	5,104 $1.17 Million
Q3 2020 Oct 30, 2020	SELL	$234.65 - $260.95 $63,824 - $70,978	-272 Reduced 5.16%	4,998 $1.27 Million
Q2 2020 Aug 11, 2020	SELL	$197.81 - $242.74 $66,068 - $81,075	-334 Reduced 5.96%	5,270 $1.24 Million
Q1 2020 May 01, 2020	SELL	$182.24 - $241.7 $25,149 - $33,354	-138 Reduced 2.4%	5,604 $1.14 Million
Q4 2019 Feb 07, 2020	SELL	$189.21 - $243.2 $54,870 - $70,528	-290 Reduced 4.81%	5,742 $1.38 Million
Q3 2019 Oct 30, 2019	SELL	$174.11 - $208.62 $71,036 - $85,116	-408 Reduced 6.34%	6,032 $1.17 Million
Q2 2019 Aug 07, 2019	SELL	$166.7 - $195.41 $16,336 - $19,150	-98 Reduced 1.5%	6,440 $1.19 Million
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $49,558 - $55,863	-274 Reduced 4.02%	6,538 $1.24 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $53.7 Million - $62.6 Million	-300,751 Reduced 97.79%	6,812 $1.33 Million
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $53.7 Million - $62.7 Million	301,103 Added 4661.04%	307,563 $1.78 Million
Q3 2018 Nov 09, 2018	SELL	$185.29 - $208.89 $35,575 - $40,106	-192 Reduced 2.89%	6,460 $1.34 Million
Q2 2018 Aug 13, 2018	SELL	$166.05 - $186.51 $141,640 - $159,093	-853 Reduced 11.37%	6,652 $1.23 Million
Q1 2018 May 10, 2018	BUY	$169.43 - $198.0 $37,613 - $43,956	222 Added 3.05%	7,505 $1.28 Million
Q4 2017 Feb 07, 2018	SELL	$168.79 - $188.59 $42,366 - $47,336	-251 Reduced 3.33%	7,283 $1.27 Million
Q3 2017 Nov 09, 2017	SELL	$167.29 - $191.0 $155,746 - $177,821	-931 Reduced 11.0%	7,534 $1.41 Million
Q2 2017 Aug 08, 2017	BUY	N/A	8,465	8,465 $1.46 Million

Others Institutions Holding AMGN

# of Institutions

2,939

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $172B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gratus Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gratus Capital LLC with notifications on news.

Account

Gratus Capital LLC Amgen Inc Transaction History